Enorama Pharma AB (ERMA)

Overview

Enorama Pharma AB (publ) is a prominent pharmaceutical company that was established in 2006. Situated in Malmö, Sweden, this firm specializes in the production and distribution of medical chewing gum and a diverse range of nicotine products. With its innovative approach, Enorama Pharma AB positions itself as a leader in offering alternative pharmacological solutions, focusing on consumer-friendly formats. Their mission extends to developing and commercializing medical cannabis products, reflecting their commitment to addressing a broad spectrum of therapeutic needs.

Products and Services

• Medical Chewing Gum:

  This product leverages the unique delivery system of chewing gum to administer medication. It is designed for users seeking an easy-to-use, discreet, and effective way to consume their medicine. The medical chewing gum line targets various therapeutic areas, providing not only a novel mode of delivery but also enhancing patient compliance.

• Nicotine Products:

  Enorama Pharma AB produces a vast array of nicotine products intended for smokers looking to quit or reduce their smoking habits. These products include nicotine chewing gum, offering a less harmful alternative to cigarettes. By focusing on nicotine replacement therapies, the company aids individuals in their journey towards smoking cessation.

• Nicotine Pouches:

  As a smokeless and spit-free alternative, nicotine pouches represent a modern approach to nicotine satisfaction without the use of tobacco. These discreet, small pouches are designed to be placed under the lip, providing a convenient and less intrusive method for nicotine intake. This innovative solution caters to users seeking to avoid the social and health impacts of smoking and dipping tobacco.

• Medical Cannabis Products:

  Recognizing the therapeutic potential of cannabis, Enorama Pharma AB has ventured into the medical cannabis market. Their products include formulations designed to meet specific medical indications, addressing a range of conditions such as chronic pain, epilepsy, and multiple sclerosis. With a commitment to research and development, the company ensures their cannabis products meet high quality and safety standards, offering patients reliable and effective treatment options.